More than 70 online on-demand seminars and syndicated reports on reimbursement and funding for medical devices and in-vitro diagnostic tests in European countries
There are almost no other ready-made materials on market access and reimbursement for medical devices, IVD test and e-health solutions in European countries
As this is a secondary project to the consulting practice of MTRC, all seminars are available at a relatively low cost.
Get a comprehensive overview of market access at the EU level or dive into specific markets (>20) and topics (such as innovation funding and HTA)
One option to access seminars is via one-demand pre-recorded webinars
Another option to access seminars is just to purchase full presentation in Acrobat PDF
Payments are accepted by organizations and individuals. You can set up access for any number of employees
A basic course (3 hours) explaining key concepts behind market access: reimbursement, funding, the need for clinical and economic evidence, health technology assessment, and stakeholder engagement using examples from 10 EU countries. Available for medical technologies and IVD tests
In-depth overviews (30-120 min) of the reimbursement systems of individual EU countries, including stakeholders, money flow, payment models, DRG systems, innovation funding, the role of HTA, and market access pathways
May 2022: Update of the overview of English hospital reimbursement system (introduced the Integrated Care Systems (ICS) as new local commissioning stakeholders, introduced Unified Tech Fund (UTF) as a mean that supports innovation, added a new slide for Evidence-based interventions program)
Update of the overview of French hospital reimbursement system (updated the overview of the transitional coverage framework and provided an example and added this framework to the summary of innovative landscape in France, mentioned that the new telemonitoring reimbursement framework is expected in 2022
Released a new free webinar on evidence requirements for market access purposes for medical technologies in Europe
April 2022: Major update of the Introduction into European market access for Med Tech companies presentation (described the reimbursement mechanism in place in England since 2021/22, removed all information regarding English innovation payment schemes which were discontinued, updated the description of the funding framework in Switzerland, introduced the HTA program (conducted by the Swiss Federal Office for Public Health) which has a goal to reassess the benefits already reimbursed by compulsory health insurance, updated the table with types of reimbursement pathways for hospital procedures in Europe; furthermore, updated the statistics and introduced various less significant changes throughout the presentation)
March 2022: Released new overviews of Belgian, Dutch, and Polish reimbursement systems for medical aids
February 2022: Major update of the Introduction into European market access for in-vitro diagnostic tests presentation (main changes include introduction of the concepts of Rapid Uptake Product and Med Tech Funding Mandate frameworks in England, introduction of a slide that describes specific programs of IVD reimbursement in Belgium, update of the Innovation Funding part by presenting Forfait Innovation framework in France, Subsidy scheme for promising care framework in the Netherlands, and Coverage with Evidence Development in Switzerland; furthermore, updated the statistics and introduced various less significant changes throughout the presentation)
January 2022: Released new overview of the Belgian hospital reimbursement system
Update of the overview of Dutch hospital reimbursement system (introduced slides describing the “other care products” (OZPs), description of the Optional Services was updated, updated various statistics throughout the presentation)
All educational materials are developed by European Med Tech and IVD Reimbursement Consulting Ltd (MTRC), one of the leading EU consulting companies
MTRC provides regular reimbursement services to 15 of the top 30 Med Tech companies
Each year, MTRC completes about 130 market access projects
The company is founded by Oleg Borisenko, MD, PhD. He has more than 13 years' experience in market access, health economics, and value developmentVisit MTRC website
17 out of top-30 global Med Tech companies regularly use reimbursement expertise of MTRC. Over last three years MTRC helped 108 Med Tech and IVD companies
MTRC provides regular services in 19 European countries. In-house coverage of major languages with the team of 15 analysts; on-demand access to local consultants
Over last three years, MTRC accomplished 401 market access projects in Europe
Send a request to [email protected], and our technical support specialist will contact you within one day.
Contact us at [email protected] and indicate that access is needed for several people. Upon confirmation of purchase, we will ask for a list of individuals and their emails to set up access to the required seminars.
Yes, you can suggest a topic to [email protected]. We will keep you informed, if and when a requested seminar is developed.
The content is developed by European Med Tech and IVD Reimbursement Consulting Ltd. (MTRC). Knowledge of the reimbursement systems was gained through multiple consulting projects and was validated through consultations with authorities or experts in individual countries.